File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: A phase I/II dose escalating trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of clevudine in patients chronically infected with HBV

TitleA phase I/II dose escalating trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of clevudine in patients chronically infected with HBV
Authors
Issue Date2003
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
The 38th Annual meeting of the European Association for the study of the liver, Istanbul, Turkey, 29 March - 1 April 2003. In Journal of Hepatology, v. 38 n. suppl. 2, p. 27, abstract no. 73 How to Cite?
DescriptionAbstract
Persistent Identifierhttp://hdl.handle.net/10722/225159
ISSN
2015 Impact Factor: 10.59
2015 SCImago Journal Rankings: 4.570

 

DC FieldValueLanguage
dc.contributor.authorMarcellin, P-
dc.contributor.authorLau, GKK-
dc.contributor.authorMommeja-Marin, H-
dc.contributor.authorSacks, S-
dc.contributor.authorSereni, D-
dc.contributor.authorBronowicki, JP-
dc.contributor.authorConway, B-
dc.contributor.authorTrepo, C-
dc.contributor.authorMondou, E-
dc.contributor.authorSnow, A-
dc.contributor.authorYoo, BC-
dc.contributor.authorLee, HS-
dc.contributor.authorRousseau, F-
dc.date.accessioned2016-04-26T02:56:58Z-
dc.date.available2016-04-26T02:56:58Z-
dc.date.issued2003-
dc.identifier.citationThe 38th Annual meeting of the European Association for the study of the liver, Istanbul, Turkey, 29 March - 1 April 2003. In Journal of Hepatology, v. 38 n. suppl. 2, p. 27, abstract no. 73-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/225159-
dc.descriptionAbstract-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleA phase I/II dose escalating trial evaluating safety, tolerability, pharmacokinetics and antiviral activity of clevudine in patients chronically infected with HBV-
dc.typeConference_Paper-
dc.identifier.emailLau, GKK: gkklau@netvigator.com-
dc.identifier.doi10.1016/S0168-8278(03)80489-0-
dc.identifier.hkuros83517-
dc.identifier.volume38-
dc.identifier.issuesuppl. 2-
dc.identifier.spage27, abstract no. 73-
dc.identifier.epage27, abstract no. 73-
dc.publisher.placeNetherlands-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats